79775-19-2 Usage
Uses
Used in Pharmaceutical Industry:
SEPTIDE is used as an antimicrobial agent for its potent activity against a wide range of bacteria, fungi, and viruses, offering a potential solution to the growing problem of antibiotic resistance.
Used in Healthcare Settings:
SEPTIDE is used as an alternative to traditional antibiotics due to its low toxicity and minimal impact on mammalian cells, making it a safer option for treating infections and reducing the risk of further resistance development.
Used in Drug-Resistant Infections:
SEPTIDE is used as a therapeutic agent for combating drug-resistant infections, providing a new approach to managing and treating these challenging cases in healthcare.
Used in Antiviral Therapies:
SEPTIDE is used as an antiviral agent, leveraging its broad-spectrum antimicrobial activity to target and neutralize viruses, offering a potential new direction for antiviral treatment development.
Check Digit Verification of cas no
The CAS Registry Mumber 79775-19-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,7,7 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 79775-19:
(7*7)+(6*9)+(5*7)+(4*7)+(3*5)+(2*1)+(1*9)=192
192 % 10 = 2
So 79775-19-2 is a valid CAS Registry Number.
InChI:InChI=1/C39H53N7O7S/c1-24(2)21-29(36(50)42-27(34(40)48)18-20-54-3)44-38(52)32-15-10-19-46(32)39(53)31(23-26-13-8-5-9-14-26)45-37(51)30(22-25-11-6-4-7-12-25)43-35(49)28-16-17-33(47)41-28/h4-9,11-14,24,27-32H,10,15-23H2,1-3H3,(H2,40,48)(H,41,47)(H,42,50)(H,43,49)(H,44,52)(H,45,51)/t27-,28-,29-,30-,31-,32-/m0/s1
79775-19-2Relevant articles and documents
6,Pro9>SP6-11, a Selective Agonist for the Substance P-P-Receptor Subtype
Laufer, Ralph,Gilon, Chaim,Chorev, Michael,Selinger, Zvi
, p. 1284 - 1288 (2007/10/02)
Substitution of a single amino acid residue, proline for glycine-9 in 6>SP6-11, a hexapeptide analogue of substance P, confers on the peptide selective agonist activity toward the SP-P receptor subtype. 6,Prosu